Cargando…

Screening for Fabry Disease by Urinary Globotriaosylceramide Isoforms Measurement in Patients with Left Ventricular Hypertrophy

Background: Left ventricular hypertrophy (LVH) is a frequent echocardiographic feature in Fabry disease (FD) and in severe cases may be confused with hypertrophic cardiomyopathy (HCM) of other origin. The prevalence of FD in patients primarily diagnosed with HCM varies considerably in screening and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gaggl, Martina, Lajic, Natalija, Heinze, Georg, Voigtländer, Till, Sunder-Plassmann, Raute, Paschke, Eduard, Fauler, Günter, Sunder-Plassmann, Gere, Mundigler, Gerald
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4879766/ https://www.ncbi.nlm.nih.gov/pubmed/27226774 http://dx.doi.org/10.7150/ijms.14997

Ejemplares similares

A Single Lung Transplant in a Patient with Fabry Disease: Causality or Far-Fetched? A Case Report
por: Gaggl, Martina, et al.
Publicado: (2013)

Pregnancies in kidney transplant recipients with complement gene variant-mediated thrombotic microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Complement-Mediated Thrombotic Microangiopathy Related to COVID-19 or SARS-CoV-2 Vaccination
por: Aigner, Christof, et al.
Publicado: (2023)

MiRNA Let-7a and Let-7d Are Induced by Globotriaosylceramide via NF-kB Activation in Fabry Disease
por: Maier, Nadine, et al.
Publicado: (2021)

Successful Pregnancies During Ongoing Eculizumab Therapy in Two Patients With Complement-Mediated Thrombotic Microangiopathy
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2020)

Sex Differences in Clinical Presentation and Outcomes among Patients with Complement-Gene-Variant-Mediated Thrombotic Microangiopathy
por: Aigner, Christof, et al.
Publicado: (2020)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort
por: Aigner, Christof, et al.
Publicado: (2021)

Effect of oral sodium bicarbonate supplementation on progression of chronic kidney disease in patients with chronic metabolic acidosis: study protocol for a randomized controlled trial (SoBic-Study)
por: Gaggl, Martina, et al.
Publicado: (2013)

Pulsed oral sirolimus in advanced autosomal-dominant polycystic kidney disease (Vienna RAP Study): study protocol for a randomized controlled trial
por: Riegersperger, Markus, et al.
Publicado: (2015)

Thrombotische Mikroangiopathien: Relevante Neuigkeiten für den Intensivmediziner
por: Gaggl, M., et al.
Publicado: (2016)

Effect of Oral Sodium Bicarbonate Treatment on 24-Hour Ambulatory Blood Pressure Measurements in Patients With Chronic Kidney Disease and Metabolic Acidosis
por: Gaggl, Martina, et al.
Publicado: (2021)

Identification of Genetic Risk Factors for Keratinocyte Cancer in Immunosuppressed Solid Organ Transplant Recipients: A Case-Control Study
por: Sunder-Plassmann, Raute, et al.
Publicado: (2023)

Comparative pharmacokinetic study of two mycophenolate mofetil formulations in stable kidney transplant recipients
por: Sunder-Plassmann, Gere, et al.
Publicado: (2012)

SARS-CoV-2 IgG spike protein antibody response in mRNA-1273 Moderna(®) vaccinated patients on maintenance immunoapheresis – a cohort study
por: Gaggl, Martina, et al.
Publicado: (2022)

Pregnancy Outcome after Exposure to Migalastat for Fabry Disease: A Clinical Report
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2019)

Late Conversion of Kidney Transplant Recipients from Ciclosporin to Tacrolimus Improves Graft Function: Results from a Randomized Controlled Trial
por: Plischke, Max, et al.
Publicado: (2015)

Neuroradiological differentiation of white matter lesions in patients with multiple sclerosis and Fabry disease
por: Rath, Jakob, et al.
Publicado: (2022)

Randomized, Single Blind, Controlled Trial to Evaluate the Prime-Boost Strategy for Pneumococcal Vaccination in Renal Transplant Recipients
por: Tobudic, Selma, et al.
Publicado: (2012)

Detection of sympathetic denervation defects in Fabry disease by hybrid [(11)C]meta-hydroxyephedrine positron emission tomography and cardiac magnetic resonance
por: Gatterer, Constantin, et al.
Publicado: (2023)

First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2
por: Schmidt, Sophie H, et al.
Publicado: (2022)

Dysregulation of tissue and serum microRNAs in organ transplant recipients with cutaneous squamous cell carcinomas
por: Geusau, Alexandra, et al.
Publicado: (2020)

Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease
por: Sueoka, Hideaki, et al.
Publicado: (2015)

Skin Globotriaosylceramide 3 Load Is Increased in Men with Advanced Fabry Disease
por: Üçeyler, Nurcan, et al.
Publicado: (2016)

Determination of globotriaosylceramide analogs in the organs of a mouse model of Fabry disease
por: Ishii, Satoshi, et al.
Publicado: (2020)

Epidemiology of Uromodulin-Associated Kidney Disease – Results from a Nation-Wide Survey
por: Lhotta, Karl, et al.
Publicado: (2012)

Long-term multisystemic efficacy of migalastat on Fabry-associated clinical events, including renal, cardiac and cerebrovascular outcomes
por: Hughes, Derralynn A, et al.
Publicado: (2023)

Long-Term Monitoring of Cardiac Involvement under Migalastat Treatment Using Magnetic Resonance Tomography in Fabry Disease
por: Gatterer, Constantin, et al.
Publicado: (2023)

Safety of switching to Migalastat from enzyme replacement therapy in Fabry disease: Experience from the Phase 3 ATTRACT study
por: Hughes, Derralynn A., et al.
Publicado: (2019)

Does administration of hydroxychloroquine/amiodarone accelerate accumulation of globotriaosylceramide and globotriaosylsphingosine in Fabry mice?
por: Tsukimura, Takahiro, et al.
Publicado: (2021)

Distinctive accumulation of globotriaosylceramide and globotriaosylsphingosine in a mouse model of classic Fabry disease
por: Taguchi, Atsumi, et al.
Publicado: (2023)

A Novel Rapid MALDI-TOF-MS-Based Method for Measuring Urinary Globotriaosylceramide in Fabry Patients
por: Alharbi, Fahad J., et al.
Publicado: (2016)

Glycosphingolipid storage in Fabry mice extends beyond globotriaosylceramide and is affected by ABCB1 depletion
por: Kamani, Mustafa A, et al.
Publicado: (2016)

A non-randomized trial of conversion from ciclosporin and tacrolimus to tacrolimus MR4 in stable long-term kidney transplant recipients: Graft function and influences of ABCB1 genotypes
por: Riegersperger, Markus, et al.
Publicado: (2019)

Correction: Globotriaosylceramide Accumulation and Not Alpha-Galactosidase-A Deficiency Causes Endothelial Dysfunction in Fabry Disease
por: Namdar, Mehdi, et al.
Publicado: (2012)

Severe nephrotic syndrome and early end-stage diabetic kidney disease in ABCC8-MODY12: A case report
por: Schmidt, Sophie H., et al.
Publicado: (2023)

COVID-19 serology in nephrology healthcare workers
por: Reiter, Thomas, et al.
Publicado: (2021)

Magnetic resonance imaging T(1)- and T(2)-mapping to assess renal structure and function: a systematic review and statement paper
por: Wolf, Marcos, et al.
Publicado: (2018)

Phenotyping of a novel COL4A4 and novel GLA variant in a patient presenting with microhematuria and mildly impaired kidney function: a case report
por: Ponleitner, Markus, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_am4juhv8120loi2giqc8o6cc48